50 related articles for article (PubMed ID: 35194724)
1. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
Zhu P; Pichardo-Rojas PS; Dono A; Tandon N; Hadjipanayis CG; Berger MS; Esquenazi Y
J Neurooncol; 2024 May; 168(1):77-89. PubMed ID: 38492191
[TBL] [Abstract][Full Text] [Related]
2. Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model.
Conrad K; Löber-Handwerker R; Hazaymeh M; Rohde V; Malinova V
J Neurooncol; 2024 Apr; ():. PubMed ID: 38639854
[TBL] [Abstract][Full Text] [Related]
3. A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy.
Jin S; Chen W; Guo X; Xing H; Yang H; Liu Q; Liu D; Zhang K; Wang H; Xia Y; Guo S; Wang Y; Shi Y; Li Y; Wang Y; Li J; Wu J; Liang T; Qu T; Li H; Yang T; Wang Y; Ma W
Discov Oncol; 2024 Mar; 15(1):85. PubMed ID: 38517553
[TBL] [Abstract][Full Text] [Related]
4. Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma.
Abdel-Rahman SA; Gabr M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275876
[TBL] [Abstract][Full Text] [Related]
5. Radio-chemotherapy feasibility for biopsy-only unresectable
Harlay V; Appay R; Bequet C; Petrirena G; Campello C; Barrié M; Autran D; Graillon T; Boissonneau S; Dufour H; Figarella-Branger D; Padovani L; Barlier A; Nanni I; Tabouret E; Chinot O
Neurooncol Pract; 2023 Dec; 10(6):536-543. PubMed ID: 38009116
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic Opening of the Blood-Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors.
Semyachkina-Glushkovskaya O; Terskov A; Khorovodov A; Telnova V; Blokhina I; Saranceva E; Kurths J
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559105
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of overall survival and postoperative neurologic deficits after resection or biopsy of butterfly glioblastoma.
Soliman MA; Khan A; Azmy S; Gilbert O; Khan S; Goliber R; Szczecinski EJ; Durrani H; Burke S; Salem AA; Lubanska D; Ghannam MM; Hess RM; Lim J; Mullin JP; Davies JM; Pollina J; Snyder KV; Siddiqui AH; Levy EI; Plunkett RJ; Fenstermaker RA
Neurosurg Rev; 2022 Dec; 45(6):3511-3521. PubMed ID: 36173528
[TBL] [Abstract][Full Text] [Related]
9. Defining the impact of adjuvant treatment on the prognosis of patients with inoperable glioblastoma undergoing biopsy only: does the survival benefit outweigh the treatment effort?
Löber-Handwerker R; Döring K; Bock C; Rohde V; Malinova V
Neurosurg Rev; 2022 Jun; 45(3):2339-2347. PubMed ID: 35194724
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
13. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
14. Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.
Matsuda M; Kohzuki H; Ishikawa E; Yamamoto T; Akutsu H; Takano S; Mizumoto M; Tsuboi K; Matsumura A
J Clin Neurosci; 2018 Apr; 50():172-176. PubMed ID: 29396060
[TBL] [Abstract][Full Text] [Related]
15. Importance and Evidence of Extent of Resection in Glioblastoma.
Wykes V; Zisakis A; Irimia M; Ughratdar I; Sawlani V; Watts C
J Neurol Surg A Cent Eur Neurosurg; 2021 Jan; 82(1):75-86. PubMed ID: 33049795
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
